Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
Mai-Chi Trieu, Fan Zhou, Sarah Larteley Lartey, Saranya Sridhar, Siri Mjaaland, Rebecca Jane Cox, Mai-Chi Trieu, Fan Zhou, Sarah Larteley Lartey, Saranya Sridhar, Siri Mjaaland, Rebecca Jane Cox
Abstract
Annual seasonal influenza vaccination is recommended for high-risk populations and often occupational groups such as healthcare workers (HCWs). Repeated annual vaccination has been reported to either have no impact or reduce antibody responses or protection. However, whether repeated vaccination influences T-cell responses has not been sufficiently studied, despite the increasing evidence of the protective roles of T-cell immunity. Here, we explored the impact of repeated annual vaccination with the same vaccine strain (H1N1pdm09) over multiple seasons in the post-2009 pandemic era and showed that repeated vaccination increased both T-cell and humoral responses. Using the T-cell FluroSpot and intracellular cytokine-staining, the hemagglutination inhibition (HI), and the memory B-cell (MBC) ELISpot assays, we investigated pre- and postvaccination T cells, antibodies, and MBCs in a cohort of HCWs repeatedly vaccinated with H1N1pdm09 for 5 years (pandemic vaccination in 2009 and subsequently annual seasonal vaccination containing H1N1pdm09 during 2010-2013). We found that the prevaccination H1N1pdm09-specific T cells, antibodies, and MBCs were significantly increased after 3-4 repeated vaccinations and maintained at high levels throughout seasons 2012 and 2013. The cross-reactive IFN-γ-secreting CD4+ cells recognizing conserved viral external or internal epitopes were also maintained throughout 2012 and 2013. Repeated vaccination improved the multifunctional memory CD4+ responses. Particularly, the IFN-γ+TNF-α+CD4+ T cells were boosted following each vaccination. HI antibodies were significantly induced after each vaccination over 5 years. Our findings indicate a broad impact of repeated annual vaccination, even with the same vaccine component, on the influenza-specific T-cell and humoral immunity and support the continuing recommendation of annual influenza vaccination. Despite the widespread implementation of annual influenza vaccination, the effect of repeated vaccinations on the immune response in subsequent seasons is poorly understood. A team led by Rebecca Jane Cox at the University of Bergen examined the humoral and T-cell response elicited by 2009's H1N1pdm09 seasonal vaccine. Since the H1N1pdm09 strain continued to circulate in subsequent years it was included in later vaccine formulations and the authors could therefore examine the effects of repeated annual vaccination over multiple seasons. They observed that H1N1pdm09-specific polyfunctional T-cell responses and antibodies were enhanced by multiple annual vaccinations. In particular, T cells showed progressive skewing to IFN-γ+TNF+ double producers, but the magnitude of the T-cell response tended to plateau after 3-4 repeated vaccinations. The findings suggest that including the same component in subsequent annual vaccines can significantly impact the influenza immune response.
Conflict of interest statement
The authors declare no competing interest.
Figures
References
- Costantino C, Vitale F. Influenza vaccination in high-risk groups: a revision of existing guidelines and rationale for an evidence-based preventive strategy. J. Prev. Med. Hyg. 2016;57:E13–E18.
- Maltezou, H. C. & Poland, G. A. Immunization of health-care providers: necessity and public health policies. Healthcare (Basel, Switzerland)4, 10.3390/healthcare4030047 (2016).
- Lansbury LE, et al. Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: a systematic review and meta-analysis. Vaccine. 2017;35:1996–2006. doi: 10.1016/j.vaccine.2017.02.059.
- Cox RJ. Correlates of protection to influenza virus, where do we go from here? Human Vaccin. Immunother. 2013;9:405–408. doi: 10.4161/hv.22908.
- Wilkinson TM, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 2012;18:274–280. doi: 10.1038/nm.2612.
- Sridhar S, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 2013;19:1305–1312. doi: 10.1038/nm.3350.
- Wang Z, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells. Nat. Commun. 2015;6:6833. doi: 10.1038/ncomms7833.
- Hayward AC, et al. Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the Flu Watch Cohort Study. Am. J. Respir. Crit. Care Med. 2015;191:1422–1431. doi: 10.1164/rccm.201411-1988OC.
- Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch. Intern. Med. 1999;159:182–188. doi: 10.1001/archinte.159.2.182.
- Belongia EA, et al. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev. Vaccin. 2017;16:1–14. doi: 10.1080/14760584.2017.1334554.
- Martinez-Baz I, et al. Effect of repeated vaccination with the same vaccine component against 2009 pandemic influenza A(H1N1) virus. J. Infect. Dis. 2017;215:847–855. doi: 10.1093/infdis/jix055.
- Trieu MC, et al. Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination. J. Infect. Dis. 2017;215:740–749.
- Lartey S, et al. Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains. Human Vaccin. Immunother. 2015;11:1654–1662. doi: 10.1080/21645515.2015.1048939.
- Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J. Virol. 2007;81:8468–8476. doi: 10.1128/JVI.00228-07.
- Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 2008;8:247–258. doi: 10.1038/nri2274.
- Eidem S, et al. Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations. Vaccine. 2015;33:4146–4154. doi: 10.1016/j.vaccine.2015.05.081.
- Wijnans L, Voordouw B. A review of the changes to the licensing of influenza vaccines inEurope. Influenza Other Respir. Virus. 2016;10:2–8. doi: 10.1111/irv.12351.
- Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Sci. (New York, NY) 2002;298:2199–2202. doi: 10.1126/science.1076071.
- Lanzavecchia A, et al. Understanding and making use of human memory B cells. Immunol. Rev. 2006;211:303–309. doi: 10.1111/j.0105-2896.2006.00403.x.
- Andrews SF, et al. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response. J. Virol. 2015;89:3308–3317. doi: 10.1128/JVI.02871-14.
- Sasaki S, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS ONE. 2008;3:e2975. doi: 10.1371/journal.pone.0002975.
- Dolfi DV, et al. Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. PLoS ONE. 2013;8:e77164. doi: 10.1371/journal.pone.0077164.
- Ramsay LC, et al. The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis. Bmc Med. 2017;15:159. doi: 10.1186/s12916-017-0919-0.
- McLean HQ, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin. Infect. Dis. 2014;59:1375–1385. doi: 10.1093/cid/ciu680.
- Belongia EA, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect. Dis. 2016;16:942–951. doi: 10.1016/S1473-3099(16)00129-8.
- Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004;22:745–763. doi: 10.1146/annurev.immunol.22.012703.104702.
- Bonduelle O, et al. Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination. J. Immunol. (Baltimore, Md.: 1950) 2013;191:623–631. doi: 10.4049/jimmunol.1203483.
- Schmidt T, et al. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. Eur. J. Immunol. 2012;42:1755–1766. doi: 10.1002/eji.201242393.
- Leddon SA, Richards KA, Treanor JJ, Sant AJ. Abundance and specificity of influenza reactive circulating memory follicular helper and non-follicular helper CD4 T cells in healthy adults. Immunology. 2015;146:157–162. doi: 10.1111/imm.12491.
- DiPiazza A, Richards KA, Knowlden ZA, Nayak JL, Sant AJ. The Role of CD4 T cell memory in generating protective immunity to novel and potentially pandemic strains of influenza. Front. Immunol. 2016;7:10. doi: 10.3389/fimmu.2016.00010.
- Scherle PA, Gerhard W. Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. Proc. Natl. Acad. Sci. USA. 1988;85:4446–4450. doi: 10.1073/pnas.85.12.4446.
- Alam S, Knowlden ZA, Sangster MY, Sant AJ. CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection. J. Virol. 2014;88:314–324. doi: 10.1128/JVI.02077-13.
- Sridhar S, et al. Predominance of heterosubtypic IFN-gamma-only-secreting effector memory T cells in pandemic H1N1 naive adults. Eur. J. Immunol. 2012;42:2913–2924. doi: 10.1002/eji.201242504.
- Weaver JM, et al. Increase in IFNgamma(-)IL-2(+) cells in recent human CD4 T cell responses to 2009 pandemic H1N1 influenza. PLoS ONE. 2013;8:e57275. doi: 10.1371/journal.pone.0057275.
- Madhun AS, et al. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine. 2010;29:266–273. doi: 10.1016/j.vaccine.2010.10.038.
- Savic M, et al. Epitope specific T-cell responses against influenza A in a healthy population. Immunology. 2016;147:165–177. doi: 10.1111/imm.12548.
- Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods. 2004;286:111–122. doi: 10.1016/j.jim.2003.12.015.
Source: PubMed